Alemtuzumab, Fludarabine, and Busulfan Followed By Donor Stem Cell Transplant in Treating Young Patients With Hematologic Disorders

Clinical trial NCT00301834 · COMPLETED

Trial details

NCT number: NCT00301834
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Congenital Amegakaryocytic Thrombocytopenia Diamond-blackfan Anemia Leukemia Myelodysplastic Syndromes Severe Congenital Neutropenia

Start date: 2005-01-01
Primary completion: 2011-09-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.